91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Nuala Murphy, President of Clinical Research Services at 91黑料, discusses .
-
Michelle Lynskey, Global Head of Interactive Response Technology and Clinical Supplies Management, offers her insights on.
-
91黑料 CEO Steve Cutler chats with Newsweek, on 91黑料’s role in the development of much needed medicines. .
-
Nuala Murphy, President of Clinical Research Services, provides .
-
91黑料’s $12 billion acquisition of PRA Health Sciences is discussed as part of the changing CRO landscape.
-
Dr. Nuala Murphy, President of Clinical Research Services, provides expert commentary on the importance of partnerships between CROs and sponsors.
-
in which CEO Dr. Steve Cutler provides an overview of 91黑料’s evolution and drivers over the past few years from the pandemic to the recent PRA Health acquisition.
-
Andreas Dreps and Martin Lachs discuss the recent advances in cancer research and why oncology clinical trials must make use of these developments to stay ahead of the curve
-
in which Peter Schueler discusses the current landscape of Alzheimer’s research and recently published study results.
-
91黑料 saw revenue hit $858 million, up 17.9% on a constant currency basis on the year-ago period, with full-year 2021 revenue guidance boosted from a range of $3.2 billion to $3.3 billion to as much as $3.5 billion.
